Clinical Evaluation Of A New Two-Component Self-Etch Universal Adhesive
XTR
1 other identifier
interventional
24
1 country
1
Brief Summary
This randomized clinical trial evaluates the clinical performance of a new two-component self-etch universal adhesive, OptiBond XTR, when applied in non-carious Class V cervical lesions without macromechanical retention (retentive grooves or bevels). The control material is OptiBond FL, a "traditional" etch/prime/bond adhesive with documented clinical performance. Eighty non-carious Class V cervical lesions are divided into two groups to be treated with either OptiBond XTR or OptiBond FL. Both adhesives are applied strictly according to the manufacturer's directions. Herculite Ultra, a nano-hybrid resin-based composite, is used as the restorative material with both adhesives. The restorations will be evaluated at insertion (baseline), 6 months, and 18 months. An optional three-year recall evaluation is also proposed. The investigators hypothesize that both adhesives will have comparable performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2011
CompletedFirst Posted
Study publicly available on registry
November 4, 2011
CompletedStudy Start
First participant enrolled
December 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedResults Posted
Study results publicly available
July 27, 2015
CompletedJuly 27, 2015
July 1, 2015
2.2 years
October 25, 2011
June 19, 2015
July 24, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retention
Overall retention of restorations
6 and 18 months post-baseline
Secondary Outcomes (6)
Color Match
18 months post-baseline
Cavosurface Margin Discoloration
18 months post-baseline
Secondary Caries
18 months post-baseline
Anatomic Form
18 months post-baseline
Marginal Adaptation and/or Integrity
18 months post-baseline
- +1 more secondary outcomes
Study Arms (2)
Adhesive OptiBond XTR
EXPERIMENTALAdhesive OptiBond XTR will include composite restorations placed using the dental adhesive OptiBond XTR.
Adhesive OptiBond FL
ACTIVE COMPARATORAdhesive OptiBond FL will include composite restorations placed using the dental adhesive OptiBond FL.
Interventions
The intervention in Arm 1 (Adhesive: OptiBond XTR; Composite: Herculite Ultra) is a 2-step, self-etching adhesive.
Arm 2 (Adhesive: OptiBond FL; Composite: Herculite Ultra) is a 3-step, etch-and-rinse adhesive.
Eligibility Criteria
You may qualify if:
- Subjects needing restoration of NCCLs (these include some cases where the patient has hypersensitivity and a restoration is indicated)
- Subjects with age range 18-80 years old
- Teeth with normal occlusion relationships
You may not qualify if:
- Subjects with fewer than 20 teeth
- Subjects with poor oral hygiene and/or uncontrolled periodontal disease
- Teeth with NCCLs with mechanical undercuts
- Subjects with known allergies to HEMA or resin-based materials. The materials to be used are HEMA and/or resin-based materials.
- Subjects with medical conditions that contraindicate dental treatment.
- Subjects with xerostomia. Xerostomia is a condition where there is a decrease salivary flow (dry mouth). Decrease salivary flow is a known factor that affects the long-term prognosis of dental restorations, and would be a confounder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of North Carolina, Chapel Hilllead
- Kerr Corporationcollaborator
Study Sites (1)
University of North Carolina at Chapel Hill School of Dentistry
Chapel Hill, North Carolina, 27599, United States
Results Point of Contact
- Title
- Dr. Andre Ritter, Professor and Chair
- Organization
- University of North Carolina at Chapel Hill School of Dentistry
Study Officials
- PRINCIPAL INVESTIGATOR
André V Ritter, DDS, MS
University of North Carolina, Chapel Hill
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor UNC School of Dentistry
Study Record Dates
First Submitted
October 25, 2011
First Posted
November 4, 2011
Study Start
December 1, 2011
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
July 27, 2015
Results First Posted
July 27, 2015
Record last verified: 2015-07